What is HMG?

HMG stands for human menopausal gonadotropin, also called menotropin. It is a urine-derived preparation with both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity (Deeks 2018). It is a protein hormone mixture rather than a single small peptide. This article summarises the published literature, which comes almost entirely from fertility medicine, and states where the evidence stops. Stackpure supplies HMG for laboratory research only.

Composition

HMG comes from the urine of postmenopausal women and mainly contains FSH, LH and hCG (Huang 2026). Commercial hCG and hMG preparations have heterogeneous compositions. In human primary granulosa cells in vitro, four urinary hCG or menotropin preparations and one recombinant preparation mediated preparation-specific signalling and early steroidogenesis, although similar progesterone plateau levels were reached after 24 hours (Riccetti 2017).

FindingModelSource
Urine-derived preparation containing both FSH and LH activity; different endocrine profile from recombinant FSHReview of clinical studiesDeeks 2018
Pregnancy rates as good as recombinant FSH in IVF/ICSI, with a lower oocyte yieldReview of clinical studiesDeeks 2018
Derived from the urine of postmenopausal women; mainly contains FSH, LH and hCGLC-MS/MS composition studyHuang 2026
Commercial hCG and hMG preparations have heterogeneous compositions and preparation-specific cell signallingHuman primary granulosa cells in vitroRiccetti 2017
rFSH plus rLH versus hMG: results differ by age group and procedureMeta-analysis, 2,767 patients, 9 studiesWang 2020

Published clinical literature

A review of a highly purified HMG product describes it as an option for controlled ovarian stimulation in assisted reproduction and for ovulation induction, with a different endocrine profile from recombinant FSH. In IVF and ICSI it gave pregnancy rates as good as recombinant FSH despite a lower oocyte yield (Deeks 2018). A meta-analysis of 9 studies in 2,767 patients compared recombinant FSH plus LH with HMG alone. It found the combination superior for clinical pregnancy rate and endometrial thickness in some subgroups, so the comparison depends on patient group and procedure (Wang 2020). A 2026 systematic review compared oocyte numbers for r-hFSH:r-hLH in a 2:1 ratio against highly purified HMG (Dahan 2026).

What the sources do not show

  • The sources checked describe licensed fertility products used in clinical settings, not research-grade vials, nasal sprays or pre-mixed formats.
  • No source checked reports stability or storage data for research formats.
  • No source checked gives a research dose, and Stackpure does not give dosing guidance.
  • The search term "hmg" alone mostly refers to unrelated topics, so this page is about human menopausal gonadotropin only.

Related research products and tools

Frequently Asked Questions

What is HMG?

Human menopausal gonadotropin (menotropin), a urine-derived preparation with both FSH and LH activity (Deeks 2018).

What does HMG contain?

It is derived from the urine of postmenopausal women and mainly contains FSH, LH and hCG (Huang 2026).

Is HMG the same as recombinant FSH?

No. It has a different endocrine profile and composition from recombinant FSH (Deeks 2018, Riccetti 2017).

Key References

  • Deeks ED. Highly purified human menopausal gonadotropin (Menopur): a profile of its use in infertility. Clin Drug Investig. 2018. PubMed 30264288
  • Huang Y, et al. Reverse-phase high-performance liquid chromatography/mass spectrometry for component analysis of human menopausal gonadotropin. J Mass Spectrom. 2026. PubMed 41952441
  • Riccetti L, et al. Heterogeneous hCG and hMG commercial preparations result in different intracellular signalling but induce a similar long-term progesterone response in vitro. Mol Hum Reprod. 2017. PubMed 29044421
  • Wang Y, et al. Comparison of the combination of recombinant FSH and recombinant LH protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: a systematic review and meta-analysis. J Evid Based Med. 2020. PubMed 32627395
  • Dahan MH, et al. Comparative effectiveness of recombinant human FSH:LH in a 2:1 ratio versus highly purified human menopausal gonadotropin alone in ovarian stimulation: a systematic review and meta-analysis. Gynecol Obstet Invest. 2026. PubMed 41729769

For research use only. Not for human consumption.